ISPAND

Serial Number 86268597
606

Registration Progress

Application Filed
May 1, 2014
Under Examination
Dec 29, 2015
Approved for Publication
Nov 3, 2015
Published for Opposition
Nov 3, 2015
Registered

Trademark Image

ISPAND

Basic Information

Serial Number
86268597
Filing Date
May 1, 2014
Published for Opposition
November 3, 2015
Abandonment Date
February 4, 2019
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Feb 4, 2019
Classes
005

Rights Holder

JOHNSON & JOHNSON

03
Address
One Johnson & Johnson Plaza
New Brunswick, NJ 089337001

Ownership History

JOHNSON & JOHNSON

Original Applicant
03
New Brunswick, NJ

JOHNSON & JOHNSON

Owner at Publication
03
New Brunswick, NJ

Legal Representation

Attorney
Brian T. Jaenicke

USPTO Deadlines

All Deadlines Cleared

All 8 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

45 events
Date Code Type Description Documents
Feb 4, 2019 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Feb 4, 2019 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
May 17, 2018 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 16, 2018 EX5G S SOU EXTENSION 5 GRANTED Loading...
May 8, 2018 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 8, 2018 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 6, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 4, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 4, 2017 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 4, 2017 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 25, 2017 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 23, 2017 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 23, 2017 EXT3 S SOU EXTENSION 3 FILED Loading...
May 23, 2017 EX3G S SOU EXTENSION 3 GRANTED Loading...
Dec 1, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 30, 2016 EX2G S SOU EXTENSION 2 GRANTED Loading...
Nov 18, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 18, 2016 EXT2 S SOU EXTENSION 2 FILED Loading...
Jul 2, 2016 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jul 1, 2016 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 1, 2016 EX1G S SOU EXTENSION 1 GRANTED Loading...
May 31, 2016 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 31, 2016 EXT1 S SOU EXTENSION 1 FILED Loading...
Dec 29, 2015 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 3, 2015 PUBO A PUBLISHED FOR OPPOSITION Loading...
Nov 3, 2015 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 14, 2015 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 25, 2015 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 25, 2015 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Sep 4, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 3, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Sep 3, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Mar 6, 2015 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 6, 2015 GNRT O NON-FINAL ACTION E-MAILED Loading...
Mar 6, 2015 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 13, 2015 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 13, 2015 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 6, 2015 ALIE A ASSIGNED TO LIE Loading...
Jan 28, 2015 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 30, 2014 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jul 30, 2014 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jul 30, 2014 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jul 25, 2014 DOCK D ASSIGNED TO EXAMINER Loading...
May 15, 2014 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 5, 2014 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular diseases, central nervous system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, and ophthalmic diseases
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005